Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients ≥70 Years Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure [SENIORS])

Rudolf A. de Boer, Wolfram Doehner, Iwan C C van der Horst, Stefan D. Anker, Daphne Babalis, Michael Roughton, Andrew J. Coats, Marcus D. Flather, Dirk J. van Veldhuisen

Research output: Contribution to journalArticle

Abstract

The beneficial effects of β blockers in younger patients with heart failure (HF) due to systolic dysfunction are well established. However, data from patients ≥70 years old with diabetes mellitus and HF are lacking. The Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS] tested the efficacy of the vasodilator β blocker nebivolol in patients ≥70 years old with HF and impaired or preserved left ventricular ejection fraction. In the present analysis, we evaluated the association between diabetes mellitus and baseline glucose levels on the primary outcome (all-cause mortality and cardiovascular hospitalization) and secondary end points, including all-cause mortality, cardiovascular hospitalizations, and cardiovascular mortality. Of 2,128 patients, 555 (26.1%) had diabetes mellitus. Of the 555 patients with diabetes mellitus, 223 (40.2%) experienced the primary end point compared to 484 (30.8%) of the 1,573 nondiabetic patients (p

Original languageEnglish
JournalThe American Journal of Cardiology
Volume106
Issue number1
DOIs
Publication statusPublished - Jul 1 2010

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this